Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2015-04-30 Regulatory Filings
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Change in substantial holding 2 pages 105.2KB
Regulatory Filings
2015-04-30 English
Invion appoints Mr Brett Heading as Chairman 2 pages 225.5KB
Board/Management Information Classification · 100% confidence The document is an ASX media announcement dated 29 April 2015, reporting the retirement of Dr Ralph Craven from the Board of Directors and the appointment of Mr Brett Heading as Chairman. It focuses on changes in the company's board composition and leadership roles. There is no financial data, earnings information, or detailed report content. The document is clearly an announcement about board/management changes rather than a full report or other filing type. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 4012 characters, which is consistent with an announcement rather than a full report.
2015-04-28 English
Final Directors Interest Notice - Dr Ralph Craven 2 pages 185.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including fully paid ordinary shares and share options, and notes the date the director ceased to be a director. This type of document is a report of personal share transactions or holdings by a company director, which aligns with the definition of Director's Dealing filings. The document length is short and focused solely on director's interests, with no financial statements or other report content. Therefore, the correct classification is Director's Dealing (DIRS).
2015-04-28 English
Appendix 4C - quarterly 5 pages 232.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'APPENDIX 4C' and is an ASX announcement dated 29 April 2015. It reports quarterly cash flow information for the quarter ending 31 March 2015, including cash reserves, operating expenses, R&D spend, and financing activities such as placements and rights issues. The document contains detailed financial data including consolidated statement of cash flows, payments to directors, financing facilities, and reconciliation of cash. Appendix 4C is a standard quarterly cash flow report required by the ASX for entities admitted on the basis of commitments. The document is about a quarterly financial report with substantive financial data and analysis, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2015
2015-04-28 English
Appendix 3Y - B Heading 3 pages 282.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change, and other related information. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It is not an annual report, earnings release, or any other financial report but specifically a director's dealing notice. Therefore, the correct classification is 'DIRS' (Director's Dealing). The document length is 3877 characters, which is consistent with a detailed insider trading notice rather than a full financial report or announcement.
2015-04-27 English
Appendix 3Y - G Collier 3 pages 282.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares held before and after the change, nature of the interest, and dates. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other financial report type. It is a regulatory filing specific to director share transactions.
2015-04-27 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.